Xencor Reports Fourth Quarter and Full Year 2023 Financial Results Read more about Xencor Reports Fourth Quarter and Full Year 2023 Financial Results
Xencor Reports Third Quarter 2023 Financial Results Read more about Xencor Reports Third Quarter 2023 Financial Results
Xencor Reports Second Quarter 2023 Financial Results Read more about Xencor Reports Second Quarter 2023 Financial Results
Xencor Reports First Quarter 2023 Financial Results Read more about Xencor Reports First Quarter 2023 Financial Results
Xencor Reports Fourth Quarter and Full Year 2022 Financial Results Read more about Xencor Reports Fourth Quarter and Full Year 2022 Financial Results
Xencor Reports Third Quarter 2022 Financial Results Read more about Xencor Reports Third Quarter 2022 Financial Results
Xencor Reports Second Quarter 2022 Financial Results Read more about Xencor Reports Second Quarter 2022 Financial Results
Xencor Reports First Quarter 2022 Financial Results Read more about Xencor Reports First Quarter 2022 Financial Results
Xencor Reports Fourth Quarter and Full Year 2021 Financial Results Read more about Xencor Reports Fourth Quarter and Full Year 2021 Financial Results
Xencor Reports Third Quarter 2021 Financial Results and Announces Encouraging Preliminary Data from Ongoing Phase 1 Study of Potency-reduced IL15-Fc Cytokine, XmAb306 Read more about Xencor Reports Third Quarter 2021 Financial Results and Announces Encouraging Preliminary Data from Ongoing Phase 1 Study of Potency-reduced IL15-Fc Cytokine, XmAb306
